Biotechnology Research & Development specialist
Total raised: $61.29M
Investors 5
| Date | Name | Website |
| - | Idinvest P... | idinvest.c... |
| 14.09.2026 | Agoranov | agoranov.c... |
| - | Kurma Part... | kurmapartn... |
| 25.03.2021 | Hadean Ven... | hadeanvent... |
| - | Pontifax V... | pontifax.c... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 19.02.2026 | Grant | $2.92M | - |
| 25.03.2021 | Series B | $41.35M | - |
| 21.11.2017 | Series A | $17.03M | - |
Mentions in press and media 11
| Date | Title | Description |
| 19.02.2026 | Step Pharma Raises €2.5M Grant from the European Innovation Council | Step Pharma, a Saint-Genis-Pouilly, France-based developer of targeted cancer therapies, raised a €2.5m grant from the European Innovation Council (EIC). The award consists of a finance package that includes the initial grant and a potentia... |
| 24.10.2022 | Step Pharma Announces First Patient Dosed with STP938, the World’s Most Advanced CTPS1 Inhibitor, in a Phase 1/2 Trial for T cell and B cell lymphomas | Step Pharma Announces First Patient Dosed with STP938, the World’s Most Advanced CTPS1 Inhibitor, in a Phase 1/2 Trial for T cell and B cell lymphomas • Potential first-in-class targeted treatment for relapsed/refractory T cell and B cell... |
| 13.05.2022 | Hello, I must be going: Jorge Gomez is Moderna CFO for only a day; As setbacks mount, Inovio’s Joseph Kim chooses the exit ramp | Jorge Gomez → David Meline will have to put his retirement on hold. In one of the more high-profile one-day tenures since Bill Belichick with the New York Jets, Jorge Gomez’s time as CFO at Moderna is over before it started. Gomez h... |
| 25.03.2021 | French biotech company Step Pharma raises €35 million in Series B | Step Pharma, a Paris based biotech company, announced on 24th March 2021 that it has raised €35 million in its Series B funding round. The round was led by Sunstone Life Science Ventures and Hadean Ventures, along with participation from Ku... |
| 24.03.2021 | Step Pharma Raises EUR35 Million in Series B Financing to Advance First in Class CTPS1 inhibitor into the Clinic in T Cell Malignancies | Archamps, France, 24 March 2021 Step Pharma, a biotech company developing novel drugs for oncology and autoimmune diseases, today announced the successful closing of a EUR35 million Series B financing. New investors Hadean Ventures and Sun... |
| 24.03.2021 | Step Pharma Raises €35M in Series B Financing | Step Pharma, an Archamps, France-based biotech company developing novel drugs for oncology and autoimmune diseases, closed a €35m Series B financing. New investors Hadean Ventures and Sunstone Life Science Ventures co-led the round, joining... |
| 21.11.2017 | Step Pharma Completes €14.5M Series A Financing | Step Pharma, a Paris, France-based developer of a novel class of oral nucleotide synthesis inhibitors targeting CTPS1 for the improved treatment of a range of autoimmune diseases, closed a €14.5m Series A financing. Pontifax joined existing... |
| 21.11.2017 | Step Pharma bags cash for CTPS1 autoimmune R&D drive | Step Pharma has closed a €14.5 million ($17.0 million) series A round. The financing equips the lean French biotech to prepare its CTPS1 inhibitors for clinical testing in autoimmune disorders. Sponsored by Agilent Technologies How would yo... |
| 21.11.2017 | Step Pharma bags cash for CTPS1 autoimmune R&D drive | Step Pharma has closed a €14.5 million ($17.0 million) series A round. The financing equips the lean French biotech to prepare its CTPS1 inhibitors for clinical testing in autoimmune disorders. Paris, France-based Step is built on a discove... |
| - | Step Pharma | “Home - Step Pharma” |
Show more